Nalaganje...

Cell-intrinsic, Bmal1-dependent circadian regulation of temozolomide sensitivity in glioblastoma

The safety and efficacy of chemotherapeutics can vary as a function of the time of their delivery during the day. This study aimed to improve the treatment of glioblastoma (GBM), the most common brain cancer, by testing whether the efficacy of the DNA alkylator temozolomide (TMZ) varies with the tim...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Biol Rhythms
Main Authors: Slat, Emily A., Sponagel, Jasmin, Marpegan, Luciano, Simon, Tatiana, Kfoury, Najla, Kim, Albert, Binz, Andrea, Herzog, Erik D., Rubin, Joshua B.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410359/
https://ncbi.nlm.nih.gov/pubmed/28470120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0748730417696788
Oznake: Označite
Brez oznak, prvi označite!